These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18094947)

  • 21. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.
    Pollmann R; Schmidt T; Eming R; Hertl M
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):1-25. PubMed ID: 29313220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins.
    Langenhan J; Dworschak J; Saschenbrecker S; Komorowski L; Schlumberger W; Stöcker W; Westermann J; Recke A; Zillikens D; Schmidt E; Probst C
    Exp Dermatol; 2014 Apr; 23(4):253-9. PubMed ID: 24533885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction.
    Waschke J; Bruggeman P; Baumgartner W; Zillikens D; Drenckhahn D
    J Clin Invest; 2005 Nov; 115(11):3157-65. PubMed ID: 16211092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
    Chernyavsky AI; Arredondo J; Kitajima Y; Sato-Nagai M; Grando SA
    J Biol Chem; 2007 May; 282(18):13804-12. PubMed ID: 17344213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocytosis of IgG, Desmoglein 1, and Plakoglobin in Pemphigus Foliaceus Patient Skin.
    Oktarina DAM; Sokol E; Kramer D; Jonkman MF; Pas HH
    Front Immunol; 2019; 10():2635. PubMed ID: 31781120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
    Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
    J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmunity against desmosomal cadherins in pemphigus.
    Amagai M
    J Dermatol Sci; 1999 Jun; 20(2):92-102. PubMed ID: 10379702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris.
    Kugelmann D; Anders M; Sigmund AM; Egu DT; Eichkorn RA; Yazdi AS; Sárdy M; Hertl M; Didona D; Hashimoto T; Waschke J
    Front Immunol; 2022; 13():884248. PubMed ID: 35844545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
    Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desmosomal adhesion and pemphigus vulgaris: the first half of the story.
    Cirillo N; Al-Jandan BA
    Cell Commun Adhes; 2013 Feb; 20(1-2):1-10. PubMed ID: 23368972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.
    Walter E; Vielmuth F; Wanuske MT; Seifert M; Pollmann R; Eming R; Waschke J
    Front Immunol; 2019; 10():1128. PubMed ID: 31178865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells.
    Aoyama Y; Kitajima Y
    J Invest Dermatol; 1999 Jan; 112(1):67-71. PubMed ID: 9886266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pemphigus Autoantibodies Induce Blistering in Human Conjunctiva.
    Vielmuth F; Rötzer V; Hartlieb E; Hirneiß C; Waschke J; Spindler V
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4442-4449. PubMed ID: 27750289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 150(th) anniversary series: Desmosomes and autoimmune disease, perspective of dynamic desmosome remodeling and its impairments in pemphigus.
    Kitajima Y
    Cell Commun Adhes; 2014 Dec; 21(6):269-80. PubMed ID: 25078507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients.
    Amagai M; Koch PJ; Nishikawa T; Stanley JR
    J Invest Dermatol; 1996 Feb; 106(2):351-5. PubMed ID: 8601740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.